Intangible Assets and In-Process R&D - Additional Information (Details) - USD ($) |
3 Months Ended | 9 Months Ended | ||||
|---|---|---|---|---|---|---|
Sep. 30, 2021 |
Sep. 30, 2020 |
Sep. 30, 2021 |
Sep. 30, 2020 |
Dec. 31, 2020 |
Sep. 26, 2018 |
|
| Intangible Assets and In-Process R&D, Net | $ 9,711,414 | $ 9,711,414 | $ 9,730,164 | |||
| Amortization of Intangible Assets, Total | 6,250 | $ 6,250 | 18,750 | $ 18,750 | ||
| SentrX Animal Care Inc | ||||||
| Intangible Assets and In-Process R&D, Net | 250,000 | 250,000 | $ 250,000 | |||
| Intangible Assets Expected Milestone Payable | $ 4,750,000 | $ 4,750,000 | $ 4,750,000 | |||
| X | ||||||||||
- Definition The amount of milestone payments expected in future periods for acquisition of intangible assets. No definition available.
|
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|